期刊文献+

乳房浸润性导管癌组织miR-10b和miR-195表达及意义

EXPRESSION OF MIR-10B AND MIR-195 IN BREAST INVASIVE DUCTAL CARCINOMA AND ITS SIGNIFICANCE
下载PDF
导出
摘要 目的探讨miRNA 10b(miR-10b)、miRNA 195(miR-195)在乳腺浸润性导管癌组织表达及其意义。方法收集40例乳癌病人癌组织及癌旁组织标本,应用逆转录PCR法测定组织中miR-10b、miR-195表达,并分析其与临床病理特征的关系。结果乳腺浸润性导管癌组织miR-10b、miR-195表达明显低于癌旁组织(t=4.35、5.71,P<0.05)。miR-195表达与肿瘤的大小、有无淋巴结转移及间质脉管癌栓等有关(U=-2.127^-2.083,P<0.05),miR-10b、miR-195表达与肿瘤TNM分期、雌激素受体(ER)、孕激素受体(PR)及人表皮生长因子受体-2(Her-2)表达水平无明显相关性(P>0.05)。结论乳房组织中miR-10b、miR-195表达可能为筛查和诊断乳房肿瘤的潜在生物学指标。 Objective To investigate the expression and its significance of miRNA 10b(miR-10b)and miRNA 195(miR-195)in tissues of patients with breast invasive ductal carcinoma. Methods Samples of cancer and paraneoplastic tissues of 40 breast cancer patients were collected,and the expression of miR-10 band miR-195 in the tissues was detected by using reverse transcriptase PCR,the relationship between the expression and clinicopathology was analyzed. Results The expressions of miR-10 b and miR-195 in the cancer tissue were significantly lower than that in the paraneoplastic tissue(t=4.35,5.71;P〈0.05),of which,the expression of miR-195 was associated with the size of the cancer,with or without lymph node metastasis,or intravascular cancer emboli(U=-2.127--2.083,P〈0.05).The expressions of miR-10 band miR-195 were not correlated with TNM stage,estrogen,progestogen,and Her-2(P〉0.05). Conclusion The expressions of miR-10 band miR-195 in tissue of breast cancer are expected to become potential biological parameters in screening and diagnosing breast neoplasms.
出处 《齐鲁医学杂志》 2014年第5期392-394,共3页 Medical Journal of Qilu
基金 山东省自然科学基金资助项目(ZR2012HM089)
关键词 微RNAS 乳房肿瘤 逆转录聚合酶链反应 miRNAs breast neoplasm reverse transcriptase
  • 相关文献

参考文献1

二级参考文献13

  • 1TURNER M L, SCHNORFEIL F M, BROCKER T. Micro- RNAs regulate dendritic cell differentiation and function[J]. J Immunol, 2011,187(8):3911.
  • 2SAYED I), ABI)EI.LATIF M. MicroRNAs in development and disease[J]. Physiol Rev, 2011,91(3):827-887.
  • 3ESQUELA-KERSCHER A, SLACK F J. Oncomirs-micro RNAs witha role in cancer[J].Nat RevCancer, 2006,6(4): 259 269.
  • 4ZHANG W, DAHLBERG J E, TAM W. Micro-RNAs in tu-- morigenesis:A primer[J]. Am J Pathol, 2007,171 (3):728-738.
  • 5TODOERTI K, BARBUI V, PEDR1NI O, et al. Pleiotropic anti myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miRNA 19a and miRNA 19b[J]. Haematologica, 2010,95(2):260-269.
  • 6PICHIORRI F, SUH SS, LADETTO M, ct al. MicroRNAs regulate critical genes associated with multiple myeloma patho- genesis [J].Proc Natl Acad Sci USA, 200,105(35):12885.
  • 7SCHMITTGEN T D, I.IVAK K J. AnaLyzing real-time PCR data by the comparativeC (T) method[J]. Nat Protoc, 2008, 3(6) : 1101-1108.
  • 8MAVRAKIS K J, WOLFE A L, OR1CCHIO E, et al. Ge- nome-wide RNA-mediated interference screen identifies miRNA 19 targets in Notch induced T cell acute'lymphoblastic leukae mia[J].Nat Cell Biol, 2010,12(4) :372-379.
  • 9ZHANGX, YUH, LOUJ R, etal. MicroRNA-19 (miRNA- 19) regulates tissue factor expression in breast cancer cells[J].J Biol Chem, 2011,286(2):1429-1435.
  • 10OLIVEV, BENNETTMJ, WALKER J C, etal. miRNA-19 is a key oncogenic component of miRNA 17 92[J].Genes Dev, 2009,23(24) :2839-2849.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部